You are now leaving the Lilly Medical website
The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to Lilly Medical
If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Retatrutide-Obesity
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling.
Was body composition evaluated in the retatrutide TRIUMPH-1 trial?
Body composition was not evaluated in TRIUMPH-1.
VERBAL ONLY
Was body composition evaluated in the retatrutide TRIUMPH-1 trial?
Body composition was not evaluated in TRIUMPH-1.
Body composition was not evaluated in TRIUMPH-1. However, Lilly continues to evaluate body composition and long-term outcomes across the TRIUMPH program.
Date of Last Review: June 04, 2026